Brand Name Drug Makers Aggressively Attack Generic Drugs

Steven Lieberman is interviewed regarding the firm’s representation of Mylan Pharmaceuticals Inc. in its pending lawsuit against Bristol-Myers Squibb Co. for its anti-anxiety drug, BuSpar.